Transforming growth factor (TGF)-b1 has a biphasic effect on rat intestinal epithelial (RIE) cells. By itself, TGF-b1 functions as a tumor suppressor by inhibiting the growth, migration and invasion of RIE cells. We show in this study that in conjunction with epidermal growth factor (EGF), TGF-b1 helped to augment migration, invasion and anchorage-independent growth (AIG) compared to that by EGF alone. EGF plus TGF-b1 induced a dramatic morphological change characteristic of epithelial-mesenchymal transition (EMT). The mechanism for this enhanced effect of TGF-b1 and EGF on oncogenic properties was explored by analysis of EGF-and TGF-b1-mediated signaling pathways and complementary DNA arrays. TGF-b1 augmented EGF-mediated signaling of mitogen-activated protein kinase (MAPK) and AKT by enhancing and prolonging the activation of the former and prolonging the activation of the latter. Inhibition of MAPK, but not phosphoinositide-3 kinase (PI3K), abolished TGF-b1 plus EGF-induced EMT and downregulation of E-cadherin at mRNA and protein levels. By contrast, cell migration and invasion were sensitive to inhibition of either MAPK or PI3 kinase. TGF-b1 plus EGF-induced AIG was significantly more resistant to inhibition of PI3K and MAPK compared to that induced by EGF alone. EGF and TGF-b1 synergistically induced the expression of a series of proteases including matrix metalloproteinase (MMP) 1 (collagenase), MMP3, MMP9, MMP10, MMP14 and cathepsin. Among them, the expression of MMP1, MMP3, MMP9 and MMP10 was MAPK dependent. Inhibition of the MMPs or cathepsin significantly blocked EGF plus TGF-b1-induced invasion, but had no effect on colony formation.
Introduction
Although transforming growth factor (TGF)-b1 was originally named after its ability to induce a transformed phenotype in normal rat kidney fibroblasts (de Larco and Todaro, 1978) , it has subsequently been shown to be growth inhibitory and an important regulator of homeostasis in normal epithelial cells (Massague´et al., 2000) . Targeted deletion of TGF-b1 gene predisposes mice to the development of squamous cell carcinoma (Glick et al., 1994) . Hemizygous or homozygous Tgfb1-null animals show increased incidence of chemically or spontaneously induced tumors (Tang et al., 1998) . Several components of the TGF-b signaling pathway have been found to act as tumor suppressors. Homozygous mutations or deletions in the genes encoding TGF-b1 I receptors, Smad2 and Smad4 have been found in various human cancers (reviewed in Massague´et al., 2000) . These observations suggest that TGF-b1 signaling functions to maintain homeostasis and suppress tumor development of normal epithelial cells.
The transforming potential of TGF-b was rediscovered when it was shown that pretreatment of adenocarcinoma cells with TGF-b1 in vitro enhanced their metastatic ability when injected into syngeneic rats (Welch et al., 1990) . Numerous studies have demonstrated that TGF-b1 can drive malignant progression by its pleiotropic effects on tumor cells (invasion and metastatic spread) and their microenvironment (angiogenesis and immunosuppression) (Massague´et al., 2000) . Advanced stage tumors often have an elevated expression of TGF-b1 (Gold, 1999) . TGF-b1 was shown to induce epithelial-mesenchymal transition (EMT), a pre-requisite for tumor cell migration and invasion, in a variety of cells (reviewed in Massague´et al., 2000) .
Among the hallmark properties of oncogenic transformed cells are anchorage-independent survival and growth (Wang, 2004) and the ability to migrate and invade for which EMT is a preceding step. Molecular signalings underlying those oncogenic properties have been studied extensively. They include activation of various receptor protein tyrosine kinases (RPTKs) (Blume-Jensen and Hunter, 2001 ) and their major down stream mediators such as MAP kinase and phosphoinositide-3 (PI3) kinase/AKT pathways (Wang, 2004) . PI3 kinase/AKT signaling is known to play an important role in protecting cells from anoikis and promoting anchorage-independent growth (AIG) (Uttamsingh et al., 2003; Wang, 2004) . Indeed, overexpression and/or activation of RPTKs (Blume-Jensen and Hunter, 2001 ) and AKT (Fresno Vara et al., 2004) have been implicated in a variety of human malignancy. Activation of RPTKs, including epidermal growth factor receptor (EGFR), has been shown to potently promote EMT in a variety of epithelial cells (Thiery, 2003) . Nevertheless, EMT itself is not sufficient to endow cancer cells the capability for invasion. Matrix metalloproteinases (MMPs) are known to be required for tissue invasion of cancer cells (reviewed in Itoh and Nagase, 2002) . Identification of the basis for regulation of MMPs in tumor cells is thus important for the understanding of metastasis.
As described above, TGF-b1 appears to have a dual effect in tumorigenesis. It can act as a tumor suppressor in the pre-tumor stage, and as a tumor promoter in late stage of tumorigenesis. It is likely that during tumorigenesis, as a result of genetic and/or epigenetic changes, the balance between those opposing functions of TGFb1 changes resulting in a switch to tumor promotion; however, the precise mechanism for this switch remains elusive.
We found that TGF-b1 has a biphasic effect on normal rat intestinal epithelial (RIE) cells. TGF-b1 by itself inhibits the growth, migration and invasion. However, when combined with a second stimulus, ex EGF, TGF-b1 cooperates with EGF to enhance EMT, migration, invasion and AIG of RIE cells. We hypothesize that the switch of TGF-b1 function can occur upon convergence and interaction with other growth factors and RPTKs. The biphase effect of TGFb1 on non-transformed RIE cells provides one a model system for elucidating the mechanism of interaction between TGF-b1 and EGF in the manifestation of oncogenic properties. Our study revealed the enhanced effect of EGF and TGF-b1 on activation of specific signaling pathways and genes involved in regulating distinct oncogenic properties.
Results
Effect of TGF-b1 and/or EGF on morphological change of RIE cell The RIE cells assume a cobble-stone shape with apicalbasal polarity and tight junctions (Figure 1a) . RIE cells treated with TGF-b1 had no changes in cell shape and junctions ( Figure 1a) . RIE cells treated with EGF appeared denser and more refractile than the control cells, but without a significant morphological change (Figure 1a) . TGF-b1 and EGF together induced a dramatic morphological change characteristic of EMT (Figure 1a) , which was noticeable as early as 90 min and virtually complete by 12 h (Figure 1c) , and was totally reversible 24 h after removal of the growth factors (data not shown). Pretreatment with TGF-b1 for 6 h followed by its removal and subsequent treatment with EGF for additional 18 h achieved a similar effect of EMT as continued treatment with both growth factors ( Figure 1b) . The converse treatment, that is pretreatment with EGF followed by TGF-b1, by contrast, only slightly promoted EMT (Figure 1b) . The observed EMT induced by EGF and TGF-b1 is not specific to a given cell line and the additive effect between TGF-b1 and a growth factor on EMT is not restricted to EGF (see more details in Supplementary Information).
Effect of TGF-b1 and/or EGF treatment on migration and invasion Transforming growth factor-b1 inhibited the migration and invasion of RIE cells by about 50% (Figure 1d ), EGF promoted the same about twofold and combination of the two increased the ability four to fivefold (Figure 1d ). Thus, together with EGF, TGF-b1 helps to greatly enhance the migration/invasion activity of RIE cells.
Effect of TGF-b1 and/or EGF treatment on monolayer and anchorage-independent growth of RIE cells Transforming growth factor-b1 and EGF treatment had opposing effects on the growth of RIE cells in monolayer (Figure 2a ). TGF-b1 inhibited the growth to 60%, whereas EGF increased the growth to 1.6-fold and combination of the two resulted in a growth rate similar to that of the control (Figure 2a) . Presumably, the growth inhibitory role of TGF-b1 counteracted the stimulating activity of EGF.
Rat intestinal epithelial cells were unable to grow in the absence of anchorage, TGF-b1 had no effect on their growth in soft agar, whereas EGF induced their colony formation. Despite its negative effect on the growth of RIE cells in monolayer, TGF-b1 dramatically enhanced EGF-induced AIG of the cells as reflected in the size, though not as much in the number, of the colonies in soft agar (Figure 2b ).
The effect of TGF-b1 and EGF on AIG of RIE cells was further tested. The cells were grown under nonadherent conditions in 1.3% methylcellulose-containing medium with or without TGF-b1 and/or EGF. TGF-b1 could not promote cell growth under such conditions (Figure 2c ), EGF resulted in about 20-50% increase of cells and their combination led to a trend of further increased growth, although only the 72 h time point was deemed to be statistically higher than that of EGF alone.
Effect of TGF-b1 and/or EGF treatment on expression of E-cadherin and b-catenin in RIE cells To understand the mechanism by which EGF and TGFb1 affect EMT and migration/invasion of RIE cells, the TGF-b1, 50 ng ml À1 EGF or a combination of both. Colonies were stained after 14 days and photographed. Colonies larger than 0.4 mm in diameter were quantified by using Image J software. A representative photomicrograph for each treatment is shown. Histograms show quantification of the colonies. (c) A total of 1.5 Â 10 6 cells were seeded in 15 ml methylcellulose medium in with or without EGF, TGF-b1 or both as above. The cells were recovered after 24, 48 or 72 h and counted. All histograms represent averages of three independent experiments. *P-values less than 0.05; **P-values less than 0.01 respectively. EGF, epidermal growth factor; RIE, rat intestinal epithelial; TGF, transforming growth factor. 4 cells were used and assayed for 2 h. For invasion assay, 1 Â 10 5 cells were used and assayed for 6 h. The histograms represent average values with standard errors from three independent experiments. **P-values are less than 0.01. DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; FCS, fetal calf serum; EMT, epithelial-mesenchymal transition; RIE, rat intestinal epithelial; TGF, transforming growth factor. expression and localization of cell-cell interaction molecules was analysed. TGF-b1 did not affect, while EGF partially decreased the level of E-cadherin ( Figure 3a , bottom panel); combination of the two greatly diminished the E-cadherin level beginning 6-9 h after the treatment (Figure 3a , bottom panel). This was corroborated by immunostaining of the cell-surface E-cadherin, which was significantly decreased in the double growth factor, but much less so in TGF-b1-or EGF-treated cells (Figure 3a , top panel). Destabilization of the Ca 2 þ -dependent E-cadherin-mediated cell-cell interactions by addition of EGTA to the growth medium resulted in an EMT-like morphological change of the cells in 1-2 h (data not shown). Together, these observations suggest that downregulation and destabilization of E-cadherin is involved in the process of EMT. The protein level of b-catenin remained unchanged upon treatment with single or combined growth factors (Figure 3a , bottom panel). However, immunofluorescence staining revealed that in TGF-b1 plus EGF-treated cells, b-catenin appeared to be less localized on the cell surface and instead was more evenly distributed throughout the cell compared with the control or single growth factor-treated cells (Figure 3a , top panel). Destabilization and/or downregulation of E-cadherin is likely to be responsible at least in part for the redistribution of b-catenin. ), TGF-b1 (5 ng ml À1 ) or both for the indicated time and proteins were extracted for western blots with anti-pERK and anti-p-AKT. Blots were stripped and reprobed with the respective antibodies for protein amount. (d) Cells were serum-starved overnight and then replenished with DMEM containing 10% FCS (untreated) or 10% FCS with EGF and/or TGF-b1. At various times, total cell lysates were analysed by western blot similarly. DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; FCS, fetal calf serum; MAPK, mitogen-activated protein kinase; RIE, rat intestinal epithelial; TGF, transforming growth factor.
Effect of TGF-b1 on EGF-induced activation of MAPK and AKT
To explore the basis underlying the cooperative effect between TGF-b1 and EGF, we examined the kinetics of the activation of ERK/mitogen-activated protein kinase (MAPK) (Figure 3b ) and AKT (Figure 3c ) in these growth factor-treated cells. TGF-b1 did not induce MAPK activation. EGF induced MAPK activation 15 min after stimulation, which was diminished after 1 h. By contrast, in the presence of TGF-b1, the EGFinduced activation of MAPK was enhanced and sustained longer (up to 24 h). TGF-b1 only induced marginal activation of AKT. EGF together with TGFb1 induced significantly prolonged AKT activation, although the peak intensity was similar to that of EGF alone. Thus, the combination of TGF-b1 and EGF results in enhanced and/or prolonged EGF-mediated signaling.
It was reported that treatment of normal rat kidney cells with TGF-b1 resulted in an increased level of EGFR (Kizaka-Kondoh et al., 2000) . Thus, we examined the effect of TGF-b1 on the kinetics of EGFR activation and stability following EGF stimulation. TGF-b1 did not significantly enhance tyrosine phosphorylation of EGFR or affect its protein level (Figure 3d ). EGF induced EGFR phosphorylation within 15 min after stimulation, which was sustained for 1 h and then decreased to the basal level after 6 h ( Figure 3d) . The EGFR protein level decreased rapidly between 1 and 6 h and was below the basal level thereafter. In the presence of both EGF and TGF-b1, tyrosine phosphorylation of EGFR was slightly higher than that of EGF alone at 12 h. EGF treatment resulted in barely detectable EGFR between 12 and 24 h; however, EGFR could still be detected at 24 h in the cells treated with EGF and TGF-b1. It is likely that the prolonged EGFR may only partially account for the sustained activation of MAPK and AKT described above. TGF-b1-mediated prolongation of EGFR after EGF stimulation required protein synthesis and was inhibited by cycloheximide, and EGF plus TGF-b1-induced EMT was also blocked by cycloheximide (data not shown).
The EGF and TGF-b1-mediated signaling pathways involved in the induction of EMT, downregulation of Ecadherin and promotion of migration/invasion We next examined the contribution of different EGF and TGF-b1-mediated signaling pathways in promoting EMT and migration/invasion and in regulating Ecadherin. The following inhibitors were used: PD98059 and U0126 for MEK, LY294002 for PI3K, rapamycin for mTOR, SB20219 for p38 MAPK, API-2 for AKT, SP600125 for JNK and AG1478 for EGFR. Inhibition of PI3K, AKT, mTOR, p38 MAPK or JNK did not block EMT (Figure 4a ) or downregulation of Ecadherin (Figure 4b ) induced by EGF and TGF-b1. By contrast, inhibition of MEK or EGFR abolished EMT (Figure 4a ) and inhibited downregulation of Ecadherin (Figure 4b) . Thus, MAPK, but not PI3K, p38 MAPK or JNK signaling, is necessary for EGF-and TGF-b1-induced EMT of RIE cells, and that this change is tightly associated with E-cadherin downregulation.
The role of different signaling pathways in mediating EGF and TGF-b1-induced migration and invasion was examined (Figure 4c ). Confirming the result in Figure 1d , TGF-b1 inhibited, while TGF-b1 plus EGF greatly enhanced migration and invasion compared to that by EGF alone. Inhibition of MAPK reduced the migration to 15 or 11%, respectively, of that treated with EGF plus TGF-b1; inhibition of PI3K reduced the migration to 21%; inhibition of mTOR or p38 MAPK decreased the migration to 37 and 41%, respectively. However, inhibition of p38 MAPK reduced the invasion-promoting activity to below 10%, which is a disparity from its effect on migration, suggesting that p38 MAPK may be involved in regulating protein(s) specifically required for invasion. Inhibition of JNK moderately inhibited the migration/invasion by 40-50%. These results show that multiple signaling pathways, especially those of PI3K and MAPK, are involved in mediating TGF-b1 and EGF-induced migration/ invasion of RIE cells.
The EGF and TGF-b1-mediated signaling pathways involved in the regulation of anchorage-independent growth Next, we assessed the contribution of different signaling pathways in EGF-or EGF plus TGF-b1-mediated promotion of AIG. The EGF-or EGF plus TGF-b1 induced colony formation was assayed with or without PD98059 or LY294002. EGF-and EGF plus TGF-b1-induced colony formation was inhibited by MAPK and PI3K inhibitors. However, it was clear that EGF plus TGF-b1-treated cells were significantly more resistant to the inhibition by those drugs individually and especially in combination (Figure 4d ). The effectiveness of those drugs was confirmed by reduced phosphorylation of MAPK and AKT, respectively, in the treated cells (data not shown). These results indicate that the ERK/MAPK and PI3K pathways play critical roles in EGF plus TGF-b1-induced AIG. TGF-b1, while by itself has no detectable activity in promoting AIG, not only augments the colony-inducing ability of EGF (Figure 2 ), but also confers the double growth factor-treated cells increased resistance to inhibitors of MAPK and PI3K (Figure 4d ). Both MAPK and PI3K signaling pathways are closely involved in EGF plus TGF-b1-induced AIG.
Effect of EGF and TGF-b1 on gene expression profile of RIE cells
To further explore the molecular basis underlying the cooperative effect between EGF and TGF-b1 in promoting oncogenic properties, we performed complementary DNA microarray analysis. Total RNAs were prepared from control and EGF plus TGF-b1-treated RIE cells with or without the PI3K or MAPK inhibitor. The whole-genome GeneChip Rat Genome 230 2.0 Array representing over 30 000 transcripts and variants derived from 28 000 well-substantiated rat genes were used.
Our results revealed that about 1200 and 1000 genes, respectively, were up and downregulated at least twofold by treatment of RIE cells with EGF plus TGF-b1. They represent genes of diversified nature and functions. Among them, 217 upregulated and 207 downregulated genes were MAPK dependent, while 117 upregulated and 233 downregulated genes were PI3K dependent. Of notice were a series of EGF plus TGF-b1-induced and MAPK-dependent genes coding for a series of matrix metalloproteinases including MMP1 (collagenase), MMP3, MMP9 and MMP10. In addition, cathepsin and neuraminidase were also upregulated. These genes along with several others were further investigated. The expression of those genes was confirmed by semiquantitative reverse transcriptase-PCR (RT-PCR) (Figure 5) . The upregulation of MMP1, MMP3, MMP9 and MMP10 and G o S 2 (G o /G 1 switch gene 2), a cell-cycle regulatory gene, required both EGF and TGF-b1, and the induction was MAPK, but not AP-1 dependent ( Figure 5 ). Additional genes induced by EGF or EGF plus TGF-b1 included PLCd4, GM-CSF, CSF3, Cox2, PAI-2A (plasminogen activator inhibitor 2A) and PTPrZ1 (Z polypeptide 1 of a receptor type protein tyrosine phosphatase). Among them, upregulation of PLCd4 and PTPrZ1 was also MAPK dependent. Genes downregulated by EGF plus TGF-b1 included Ecadherin, Lot1 (loss in transformation) and connexin 26, of which downregulation of E-cadherin was MAPK dependent confirming the results described above. However, the known negative regulators of E-cadherin, Snail and Slug, were not affected by EGF, TGF-b1 or their combination. Our results indicate that certain genes, including a series of MMPs, are synergistically induced by EGF and TGF-b1 implying their possible involvement in the dual growth factor-induced oncogenic properties.
Role of EGF and TGF-b1-induced genes in the regulation of invasion and anchorage-independent growth
We inquired about the significance of those upregulated genes in EGF-and TGF-b1-induced invasion and colony formation. Treatment of the cells by pan MMP inhibitors, MMP9-specific inhibitor, as well as inhibitors of collagenase I and cathepsin, but not MMP3, significantly reduced the EGF-and TGF-b1-induced invasion (Figure 6a ). Inhibition of neuraminidase by G54071, PLC by U73122, but not Cox2 by N398, also significantly reduced invasion (Figure 6a ). Among the same series of drugs tested, the inhibitors of collagenase I, MMP9, Cox2 and PLC also resulted in a significant reduction of EGF plus TGF-b1-induced colony formation (Figure 6b ). These results indicate that EGF and TGF-b1 synergistically induced a series of genes Figure 4 The role of different signaling pathways in EGF and/or TGF-b1-induced EMT, migration, invasion and colony formation of RIE cells. Subconfluent RIE cells treated for 24 h as in Figure 1a with or without addition of 10 mM LY294002, 25 mM PD98059, 5 mM U0126, 10 ng ml À1 rapamycin, 10 mM SB202190, 10 mM SP200125, 10 ng ml À1 API-2 or 10 mM AG1478. Representative photomicrographs were taken (a). The treated cells were extracted with RIPA and 40 mg each of total cell lysate was analysed for Ecadherin expression (b). Some of the parallel cultures of the treated cells were subjected to migration and invasion assays (c). Additional parallel cultures were subjected to colony formation assay (d). The histograms represent averages of three independent experiments. **P values are less than 0.01. EGF, epidermal growth factor; EMT, epithelial-mesenchymal transition; RIE, rat intestinal epithelial; TGF, transforming growth factor.
including MMPs involved in promoting cell invasion, and some of them are also involved in promoting AIG.
Discussion
The present study demonstrates the dual effect of TGFb1 on RIE cells and the cross talk between the RPTK and TGF-b1 signaling. Our study sheds light on the mechanism by which TGF-b1 cooperates with EGF to induce EMT, as well as to promote migration/invasion and AIG of non-tumorigenic RIE cells. Our results show that EGF is able to overcome the inhibitory effect of TGF-b1 on growth, migration and invasion, while TGF-b1 functions to enhance major down stream signaling of EGFR including MAPK and AKT pathways involved in regulating EMT, migration/invasion and AIG. Moreover, EGF and TGF-b1 synergistically induce the expression of a series of genes including MMPs involved in promoting invasion or AIG. Our finding of the cooperation between EGF and TGF-b1 in inducing EMT confirms similar previous observations in RIE and other cell systems (Stolz et al., 1997; Saha et al., 1999; Docherty et al., 2006) .
Our finding of the enhancing effect between TGF-b1 and EGF in promoting AIG, migration and invasion is in agreement with the recent reports that activation of TGF-b signaling promotes pulmonary metastasis of mammary tumors in MMTV/neu transgenic mice (Siegel et al., 2003) Figure 6 The role of MMPs, cathepsin, neuraminidase, Cox2 and phospholipase C in EGF and TGF-b1-induced invasion and colony formation of RIE cells. Sub-confluent RIE cells were treated similarly as in Figure 1a with or without the addition of MMP-I (100 mM), MMP-II (50 nM), collagenase I (50 mM), MMP3-V (50 mM), MMP9/13-I (1 mM), cathepsin (50 mM), G54071 against neuraminidase (50 mM), NS398 against Cox2 (50 mM) or U73122 against phospholipase C (50 mM) for 24 h. A total of 1 Â 10 5 cells each were subjected to invasion assay in triplicates in the presence of the drugs (a). A total of 3 Â 10 4 cells each in triplicates were subjected to colony assay in the absence or presence of inhibitors (b). Colonies were quantified 2 weeks later. Histograms represent average of three experiments. **P values are less than 0.01. EGF, epidermal growth factor; MMP, matrix metalloproteinase; RIE, rat intestinal epithelial; TGF, transforming growth factor. Figure 1a with or without addition of 25 mM PD98059 or 50 mM 6-gingerol in DMEM containing 10% FCS for 24 h. Two micrograms each was subjected to RT-PCR using genespecific primers (Supplementary Table 1 ). After RT-PCR, 10 ml aliquot from each reaction was subjected to electrophoresis in 2% agarose gel containing ethidium bromide. The DNA bands were photographed under ultraviolet radiation. A representative gel pattern is shown from three independent and reproducible experiments. DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; FCS, fetal calf serum; RIE, rat intestinal epithelial; TGF, transforming growth factor.
Rat intestinal epithelial cells treated with TGF-b1 and EGF show a decrease of E-cadherin, a common characteristic of almost all human epithelial cancers (Bracke et al., 1996) . Our data show that TGF-b1 and EGF-induced EMT is initiated before substantial loss of E-cadherin in RIE cells. This suggests that while downregulation of E-cadherin is associated with EMT, for example, for its maintenance, the initiation of this process is likely to be triggered by destabilization of the E-cadherin-mediated homophilic cell-cell interactions as suggested by our observation of the treatment of RIE cells with EGTA.
Our results show that the MAPK pathway, but not the PI3K, p38MAPK, JNK or AP-1 pathways (data not shown), is required for TGF-b1 and EGF-induced downregulation of E-cadherin and EMT. Recent studies suggest that the downregulation of E-cadherin induced by combination of TGF-b1 and EGF may be due to the transcription factors Snail or Sip1, which negatively regulate the E-cadherin expression (Batlle et al., 2000; Cano et al., 2000; Comijn et al., 2001) . Our data rule out the involvement of Snail ( Figure 5 ). The expression of Sip1 was undetectable in the control or growth factortreated RIE cells, making its involvement unlikely also.
Involvement of MMPs in cancer-cell invasion has been well established. Our data show that EGF and TGF-b1 synergistically induce the expression of a series of MMPs, among them, MMP9 and MMP10 could only be detectably induced upon the combined stimulation (Figure 5a ). Although both EGF and TGF-b1 have individually been shown to induce or enhance the expression of certain MMPs (reviewed in Yan and Boyd, 2007) , to our knowledge our current study is the first to demonstrate the synergistic induction of MMPs by EGF and TGF-b1. Cathepsin, neuraminidase and the MMPs induced by EGF and TGF-b1 except MMP3 appear to be important for invasion, but not for colony formation, of the combined growth factor-treated cells. Among the other EGF-and TGF-b1-mediated up-or downregulated genes examined (Figure 5 ), Cox 2 is also involved in invasion but not in colony formation, whereas PLC appears to be important for both.
A model depicting the dual function of TGF-b1 and cooperation between EGF and TGF-b1 is shown in Supplementary Figure S1 . TGF-b1 signals to inhibit, whereas EGF significantly promotes, growth, migration and AIG. In EGF-and TGF-b1 treated cells, some of the growth inhibitory effects of TGF-b1 signaling are counteracted by EGFR signaling, which is itself augmented by TGF-b1 in part by enhancing and/or prolonging the activation of MAPK and AKT, and to some extent by stabilization of EGFR. TGF-b1 signaling cooperates with EGFR signaling to promote EMT, AIG, migration and invasion. RPTKs such as those of EGFR, ErbB2 and IGF-1R are frequently amplified and/or activated in late stage tumors. Our study helps to explain the tumor-promoting activity of TGF-b1, whose elevated expression is often found in advanced stage tumors. In theory, inhibiting the signaling pathway that cooperates with the TGF-b1 signaling may reverse TGFb1 back to its growth inhibitory effect. Future strategies for cancer treatment may invoke the tumor-suppressive function of TGF-b1 by targeting its cooperating signaling pathway(s) in promoting oncogenic properties.
Materials and methods
Cell culture and maintenance Rat intestine epithelial cells were maintained in Dulbecco's modified Eagle's medium (DMEM)-containing 10% fetal calf serum (FCS) (Nguyen et al., 2000) .
Antibodies and inhibitors
The source of antibodies and pharmacological inhibitors are provided in Supplementary Information.
Migration and invasion assays
Subconfluent RIE cells were untreated or treated with 5 ng ml À1 TGF-b1, 50 ng ml À1 EGF or a combination of both for 24 h in 10% FCS DMEM and subjected to migration assay as described previously (Sachdev et al., 2002; Cheng et al., 2007) .
Colony formation assays
Colony assay was performed as described (Cheng et al., 2007) except that 5 Â 10 4 RIE cells were suspended in the presence or absence of 50 ng ml À1 EGF, 5 ng ml À1 TGF-b1 or a combination of both in the top agar medium.
Growth rate assays in adherent and non-adherent conditions Cells were grown as adherent cultures in media containing 10% FCS with or without 5 ng ml À1 TGF-b1 and/or 50 ng ml À1 EGF or as non-adherent cultures in media containing 1.3% methylcellulose as described (Assoian et al., 1989; Uttamsingh et al., 2003) .
Protein analysis
Protein extraction, immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting have been described (Jong and Wang, 1987) .
Immunostaining
Immunostaining of E-cadherin and b-catenin of control and growth factor-treated cells followed the described procedures (Sachdev et al., 2002) except that no membrane permeation was done for E-cadherin staining.
Complementary DNA array Subconfluent culture of RIE cells were untreated or treated with EGF (50 ng ml
À1
) and TGF-b1 (5 ng ml
) with or without 25 mM PD98059 or10 mM LY294002 in 10% FCS DMEM for 24 h. Total RNAs were extracted using the RNeasy purification kits (Qiagen, Valencia, CA, USA). RNA quality was evaluated by Agilent Bioanalyzer before microarray assay. Three micrograms of RNA from each treatment condition was used to prepare biotin-labeled cRNA, which was subsequently hybridized onto the Affymetrix Rat Genome 230 2.0 array following the Affymetrix GeneChip Manual. Additional details of the analysis are described in Supplementary Information.
Reverse transcriptase-PCR
Rat intestinal epithelial cells were treated as described above for the complementary DNA array. Total RNA was similarly isolated. Two micrograms of RNA each was subjected to RT-PCR. DNA primers and details of the RT-PCR procedures are proved in Supplementary Information.
